Christian F Weber1, Matthias Klages, Kai Zacharowski. 1. Clinic of Anesthesiology, Intensive Care Medicine and Pain Therapy, Goethe-University Hospital Frankfurt, Theodor-Stern-Kai, Frankfurt am Main, Germany. Christian.Weber@kgu.de
Abstract
PURPOSE OF REVIEW: Cardiac surgery patients commonly present bleeding complications that negatively influence patient's clinical outcome. Therefore, fast and detailed diagnoses as well as early and specific therapy of perioperative coagulopathy are of high clinical relevance. The so-called point-of-care (POC) methods for coagulation analyses are increasingly used in perioperative care. It is the purpose of this review to present modern aspects of coagulation management, discuss the effect of the implementation of POC methods in perioperative care, and present substantial components of hemotherapy algorithms to manage coagulopathy in cardiac surgery patients. RECENT FINDINGS: Recent studies suggest that implementation of point-of-care testing in hemotherapy algorithms which inclose stepwise therapeutic escalation may reduce perioperative blood loss and the transfusion rate of allogenic blood products. This should improve patient's clinical outcome and reduce costs. SUMMARY: Prospective randomized multicenter studies are needed to confirm the hypothesis that algorithm-based specific hemotherapy in conjunction with POC testing minimizes patient's exposure to blood products and improves clinical outcome.
PURPOSE OF REVIEW: Cardiac surgery patients commonly present bleeding complications that negatively influence patient's clinical outcome. Therefore, fast and detailed diagnoses as well as early and specific therapy of perioperative coagulopathy are of high clinical relevance. The so-called point-of-care (POC) methods for coagulation analyses are increasingly used in perioperative care. It is the purpose of this review to present modern aspects of coagulation management, discuss the effect of the implementation of POC methods in perioperative care, and present substantial components of hemotherapy algorithms to manage coagulopathy in cardiac surgery patients. RECENT FINDINGS: Recent studies suggest that implementation of point-of-care testing in hemotherapy algorithms which inclose stepwise therapeutic escalation may reduce perioperative blood loss and the transfusion rate of allogenic blood products. This should improve patient's clinical outcome and reduce costs. SUMMARY: Prospective randomized multicenter studies are needed to confirm the hypothesis that algorithm-based specific hemotherapy in conjunction with POC testing minimizes patient's exposure to blood products and improves clinical outcome.
Authors: Michael A Gillies; Michael Sander; Andrew Shaw; Duminda N Wijeysundera; John Myburgh; Cesar Aldecoa; Ib Jammer; Suzana M Lobo; Naomi Pritchard; Michael P W Grocott; Marcus J Schultz; Rupert M Pearse Journal: Intensive Care Med Date: 2017-06-08 Impact factor: 17.440
Authors: Patrick Meybohm; Bernd Froessler; Lawrence T Goodnough; Andrew A Klein; Manuel Muñoz; Michael F Murphy; Toby Richards; Aryeh Shander; Donat R Spahn; Kai Zacharowski Journal: Perioper Med (Lond) Date: 2017-03-17